The evaluation of the effectiveness of amitriptyline versus venlafaxine in female patients diagnosed with fibromyalgia syndrome;Fibromiyalji tanili kadin hastalarin amitriptilin ve venlafaksin'in etkileri yönünden tedavi öncesi ve sonrasi deǧ erlendirilmesi

Klinik Psikofarmakoloji Bulteni

Volumn 17, Issue 2, 2007, Pages 68-73

  Güleç, Hüseyin ^a   Çapkin, Erhan ^b   Sayar, Kemal ^b   Ak, Ismail ^a  

^a SB Istanbul Erenköy Ruh ve Sinir Hastaliklari Eǧitim ve Araştirma Hastanesi ^*  (Turkey)

^b Anesteziyoloji ve Reanimasyon A D   (Turkey)

Author keywords

Adverse event; Amitriptyline; Efficacy; Fibromyalgia; Venlafaxine

Indexed keywords

AMITRIPTYLINE; VENLAFAXINE;

ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; QUESTIONNAIRE; VISUAL ANALOG SCALE;

EID: 34347327191     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Melzack R. From the gate to the neuromatrix. Pain 1999; Suppl 6: S 121-126
2. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160-172
3. Bennet RM. The fibromyalgia syndrome, myofascial pain and the chronic fatigue syndrome. Kelley WN, Harris ED, Rudy S, Sledge CB (Ed): Textbook of Rheumatology (4. Ed) WB. Saunders Company, Philadelphia 1993; 471-479
4. Maizels M, McCarberg B. Antidepressant and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 2005; 71:483-490
5. Richeimer S, Bajwa Z, Kahraman S, Ransil B, Warfield C. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey. Clin J Pain 1997; 13:324-329
6. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000; 41: 104-113
7. Bendtsen L. Amitryptiline in the treatment of primary headaches. Expert Rev Neurotherapeutics 2003; 3:165-173
8. Solerno S, Browning R, Jackson J. The effect of antidepressant treatment of chronic back pain: a meta-analysis. Arch Intern Med 2002; 162:19-24
9. Watson C, Evans R, Reed K, Merskey H, Goldsmith L, Warsh J. Amitryptiline versus placebo in postherpetic neuralgia. Neurology 1982; 32:671-673
10. Frank R, Kashani J, Parker J, Beck N, Brownlee-Duffeck M, Elliot T, Haut A, Atwood C, Smith E, Kay D. Antidepressant analgesia in rheumatoid arthritis. J Rheumatol 1988; 15:1632-1638
11. Max M, Culnane M, Schafer S, Gracely R, Walther D, Smoller B, Dubner R. Amitryptiline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37:589-596
12. Tura B, Tura S. The analgesic effect of tricyclic antidepressant. Brain Res 1990; 518:19-22
13. Ardid D, Marthy H, Fialip J, Privat A, Eschalier A, Lavarenne J. Comparative effects of different uptake inhibitors antidepressant in two pain tests in mice. Fundam Clin Pharmacol 1992; 6:75-82
14. Ashina S, Bendtsen L, Jensen R. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition. Pain 2004; 108:108-114
15. Coluzzi F, Mattia C. Mechanism-based treatment in chronic neuropathic pain: the role of antidepressants. Curr Pharm Des 2005;11:2945-2960
16. Stahl SM, Grady MM, Moret C, Briley M. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 2005;10:732-747
17. Yucel A, Ozyalcin S, Koknel Talu G, Kiziltan E, Yucel B, Andersen OK, Arendt-Nielsen L, Disci R. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study. Eur J Pain 2005;9:407-416
18. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17:45-56
19. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988; 56:893-897
20. Ulusoy M, Sahin NH, Erkmen H. Turkish version of the Beck Anxiety Inventory: Psychometric properties. J Cogn Psychother 1998; 12:163-172
21. Beck AT, Waed CH, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
22. Hisli N. Beck Depresyon Ölçeǧi'nin bir Türk örnekleminde geçerlik ve güvenirliǧi. Psikoloji Dergisi 1988; 6:118-122
23. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991; 18:728-733
24. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000; 20:9-12
25. O'Malley PG, Balden E, Tomkins G, Santore J, Kroenke K, Jackson JL. Treatment of fibromyalgia with antidepressant: a meta-analysis. J Gen Intern Med 2000; 15:659-666
26. Carette S, McCain GA, Bell DA, Fam AG. Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo-controlled study. Arthritis Rheum 1986; 29:1371-1377
27. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, Edworthy SM, Baron M, Koehler BE, Fam AG. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial. Arthritis Rheum 1994; 37:32-40
28. Carette S, Oakson G, Guimont C, Steriade M. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 1995; 38:1211-1217
29. Goldenberg DL, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized double-blind crossover trial of fluoxetine and amitriptyline in patients with fibromyalgia. Arthritis Rheum 1996; 39:1852-1859
30. Dwight MM, Arnold LM, O'Brien H, Metzger R, Morris-Park E, Keck PE Jr. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 1998; 39:14-17
31. Sayar K, Aksu G, Ak I, Tosun M. Venlafaxine treatment of fibromyalgia. Ann Pharmachother 2003; 37:1561-1565
32. Bennett RM. Sensory dysfunction in fibromyalgia and related network disorders- Implication for therapy. Contemporary issues in the neuropsychopharmacology of fibromyalgia. 25th CINP Congress, 9-13 July 2006, Chicago. Symposium Workbook.s.12